Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment (MINDBERRY)
A Randomized, Double-blind, Placebo-controlled Intervention Study to Evaluate the Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiome in Adults With Mild Cognitive Impairment The MINDBERRY Trial
Sponsor: Berry Lab
This NA trial investigates Cognitive Impairment, Mild and Memory Impairment and is currently completed. Berry Lab leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2023 — Apr 2024 [monthly]
Recruiting NA
-
Feb 2022 — Feb 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Apr 2020 — Jul 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Berry Lab
- Lund University
- Region Skane
For direct contact, visit the study record on ClinicalTrials.gov .